ATE391711T1 - Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden - Google Patents

Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden

Info

Publication number: ATE391711T1
Authority: AT; Austria
Prior art keywords: nrr; alkylene; polyfluoro; alkyl; dopamine
Prior art date: 2004-12-01

Application number

AT05822892T

Other languages

English (en)

Inventor

Marc Capet

Denis Danvy

Catherine Dartois

Nicolas Levoin

Marcel Morvan

Isabelle Berrebi-Bertrand

Thierry Calmels

Philippe Robert

Jean-Charles Schwartz

Jeanne-Marie Lecomte

Original Assignee

Bioprojet Soc Civ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-01

Filing date

2005-11-29

Publication date

2008-04-15

2005-11-29 Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE391711T1 publication Critical patent/ATE391711T1/de

Links

102000004073 Dopamine D3 Receptors Human genes 0.000 title abstract 3
108090000525 Dopamine D3 Receptors Proteins 0.000 title abstract 3
239000003446 ligand Substances 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
125000003709 fluoroalkyl group Chemical group 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
KOAGTIYEJARZPM-UHFFFAOYSA-N 1-(5-methoxy-1,3-dihydroisoindol-2-yl)-6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]hexan-1-one Chemical compound C1C2=CC(OC)=CC=C2CN1C(=O)CCCCCN(CC1)CCN1C1=CC=CC(C(F)(F)F)=C1 KOAGTIYEJARZPM-UHFFFAOYSA-N 0.000 abstract 1
230000002075 anti-alcohol Effects 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000000648 anti-parkinson Effects 0.000 abstract 1
230000002738 anti-smoking effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
239000000729 antidote Substances 0.000 abstract 1
239000000939 antiparkinson agent Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
210000005260 human cell Anatomy 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000003176 neuroleptic agent Substances 0.000 abstract 1
230000000701 neuroleptic effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
General Health & Medical Sciences (AREA)
Addiction (AREA)
Psychiatry (AREA)
Psychology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT05822892T 2004-12-01 2005-11-29 Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden ATE391711T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0412763A FR2878524B1 (fr)	2004-12-01	2004-12-01	Nouveaux derives d'arylpiperazine

Publications (1)

Publication Number	Publication Date
ATE391711T1 true ATE391711T1 (de)	2008-04-15

Family

ID=34951009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05822892T ATE391711T1 (de)	2004-12-01	2005-11-29	Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden

Country Status (12)

Country	Link
US (1)	US20080214542A1 (de)
EP (1)	EP1828125B1 (de)
AT (1)	ATE391711T1 (de)
DE (1)	DE602005006018T2 (de)
DK (1)	DK1828125T3 (de)
ES (1)	ES2302254T3 (de)
FR (1)	FR2878524B1 (de)
HR (1)	HRP20080187T3 (de)
PL (1)	PL1828125T3 (de)
PT (1)	PT1828125E (de)
SI (1)	SI1828125T1 (de)
WO (1)	WO2006058993A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090238761A1 (en) *	2005-01-03	2009-09-24	Universita Degli Studi Di Siena	Novel Aryl Piperazine Derivatives With Medical Utility
EP1870405A1 (de) *	2006-06-22	2007-12-26	Bioprojet	Carbonylierte (Aza)cyclohexane als Dopamin D3 Rezeptorliganden
EP2238125A1 (de) *	2008-02-01	2010-10-13	NeuroSearch A/S	Neue aryl-piperazin-derivate als modulatoren von dopamin- und serotonin-rezeptoren
WO2009112568A1 (en) *	2008-03-14	2009-09-17	Neurosearch A/S	Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
JP5701213B2 (ja)	2008-10-10	2015-04-15	インスティチュートオブファーマコロジーアンドトキシコロジーアカデミーオブミリタリーメディカルサイエンシズピー．エル．エー．チャイナ	新規なドーパミンｄ３受容体リガンド、その調製及び使用
US9227944B2 (en)	2008-10-10	2016-01-05	Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China	Dopamine D3 receptor ligands and preparation and medical uses of the same
WO2014079504A1 (en) *	2012-11-22	2014-05-30	Biofordrug S.R.L.	Polycyclic ligands of 5-ht7 receptor and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4704593A (en) *	1992-08-06	1994-03-03	Smithkline Beecham Plc	5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists
US5523229A (en) *	1994-03-22	1996-06-04	Trustees Of The University Of Pennsylvania	Antibodies specific for oncofetal fibronectin
EP1246817B1 (de) *	1999-12-30	2004-06-23	H. Lundbeck A/S	4-phenyl-1-piperazinyl, -piperidinyl und -tetrahydropyridyl-derivate
AU2003215558A1 (en) *	2002-02-13	2003-09-04	Glaxo Group Limited	Benzenesulfonamide derivatives as antipsychotic agents
US20040204422A1 (en) *	2003-04-14	2004-10-14	Abbott Gmbh & Co. Kg.	N-[(Piperazinyl)hetaryl]arylsulfonamide compounds

2004
- 2004-12-01 FR FR0412763A patent/FR2878524B1/fr not_active Expired - Fee Related
2005
- 2005-11-29 SI SI200530267T patent/SI1828125T1/sl unknown
- 2005-11-29 PL PL05822892T patent/PL1828125T3/pl unknown
- 2005-11-29 AT AT05822892T patent/ATE391711T1/de not_active IP Right Cessation
- 2005-11-29 US US11/720,526 patent/US20080214542A1/en not_active Abandoned
- 2005-11-29 DK DK05822892T patent/DK1828125T3/da active
- 2005-11-29 EP EP05822892A patent/EP1828125B1/de not_active Expired - Lifetime
- 2005-11-29 ES ES05822892T patent/ES2302254T3/es not_active Expired - Lifetime
- 2005-11-29 PT PT05822892T patent/PT1828125E/pt unknown
- 2005-11-29 WO PCT/FR2005/002964 patent/WO2006058993A1/fr not_active Ceased
- 2005-11-29 DE DE602005006018T patent/DE602005006018T2/de not_active Expired - Fee Related
- 2005-11-29 HR HR20080187T patent/HRP20080187T3/xx unknown

Also Published As

Publication number	Publication date
ES2302254T3 (es)	2008-07-01
HRP20080187T3 (hr)	2008-05-31
US20080214542A1 (en)	2008-09-04
DK1828125T3 (da)	2008-08-04
EP1828125B1 (de)	2008-04-09
WO2006058993A1 (fr)	2006-06-08
DE602005006018D1 (de)	2008-05-21
FR2878524B1 (fr)	2007-01-19
PL1828125T3 (pl)	2008-09-30
EP1828125A1 (de)	2007-09-05
SI1828125T1 (sl)	2008-08-31
FR2878524A1 (fr)	2006-06-02
DE602005006018T2 (de)	2008-07-10
PT1828125E (pt)	2008-08-22

Similar Documents

Publication	Publication Date	Title
ATE384052T1 (de)	2008-02-15	Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden
NO20076418L (no)	2008-03-25	Heterocyclic compounds as agonists for the thyroid receptor
DK2010531T3 (da)	2011-09-19	Spirocykliske cyklohexanderivater med smertestillende virkning
BRPI0710266B8 (pt)	2021-05-25	composto, medicamento, e, uso de um composto
TNSN05328A1 (en)	2007-07-10	(thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
AR062965A1 (es)	2008-12-17	Compuestos moduladores de receptores de glutamatometabotropicos mglur5, composiciones farmaceuticas que los contienen y usos terapeuticos en trastornos gastrointestinales, neurologicos y psiquiatricos agudos y cronicos
NO20072969L (no)	2007-08-31	Fenylpiperazinderivater med en kombinasjon av partiell dopamin-D2-receptoragonisme og serotoningjenopptaksinhibering
DE602005006018D1 (de)	2008-05-21	Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden
PE20061156A1 (es)	2006-12-16	Derivados de benzamida como agentes inhibidores del transportador de glicina
TW200531694A (en)	2005-10-01	Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
AR056321A1 (es)	2007-10-03	COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
CY1110613T1 (el)	2015-04-29	Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
ATE466842T1 (de)	2010-05-15	3-substituierte pyridinderivate als h3- antagonisten
PE20090320A1 (es)	2009-03-19	Derivados de piperidina-amida
MX2007007027A (es)	2007-07-04	Derivados piperazinilpiridina como agentes anti-obesidad.
PE20061396A1 (es)	2007-01-12	Inhibidores de quinasa del receptor del factor de crecimiento epidermico (egfr) en pacientes resistentes a gefitinib
CY1110465T1 (el)	2015-04-29	Υποκατεστημενα παραγωγα ιμιδαζολινης
MX2007003119A (es)	2007-05-24	Nuevas amidas heterociclicas.
AR048948A1 (es)	2006-06-14	Una composicion farmaceutica antimicobacteriana
HRP20070285T3 (en)	2007-08-31	Arylpiperazuine derivatives as selective ligand for the dopamine d3 receptor
PE20081299A1 (es)	2008-09-17	Analogos de pirazol
AR049671A1 (es)	2006-08-30	2-aminoimidazoles sustituidos, procedimiento para su preparacion, su uso como medicamento o ayuda al diagnostico, y medicamento que los contiene
PE20060868A1 (es)	2006-08-23	Sales de aminio de 1,2,3- triazoles como profarmacos que incluyen agentes antivirales
RU2009138032A (ru)	2011-04-20	Новое профилактическое и/или лекарственное средство против диабетической невропатии
TW200631952A (en)	2006-09-16	Benzdioxan piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites

Legal Events

Date

Code

Title

Description

2008-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1828125

Country of ref document: EP

2010-08-15

REN

Ceased due to non-payment of the annual fee